Skip to main content

Table 2 Prevalence (%) of metabolic syndrome and its components according to the R-ATPIII, IDF and JIS94/80 criteria

From: Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity

 

Elevated waist circumference 102/881

Elevated waist circumference 94/802

Elevated triglycerides

Reduced HDL-cholesterol

Elevated blood pressure

Elevated fasting glucose

Metabolic syndrome R-ATPIII

Metabolic syndrome IDF

Metabolic syndrome JIS94/80

 

%

%

%

%

%

%

%

%

%

 

(95%CI)

(95%CI)

(95%CI)

(95%CI)

(95%CI)

(95%CI)

(95%CI)

(95%CI)

(95%CI)

Total unadjusted

40.7

66.1

22.8

27.3

46.6

26.0

27.2

32.2

33.2

 

(38.6-42.7)

(64.1-68.2)

(20.8-24.7)

(25.1-29.4)

(44.6-48.6)

(24.1-28.0)

(25.2-29.2)

(30.1-34.3)

(31.2-35.3)

Total age-adjusted

39.9

65.8

22.7

27.0

44.9

25.0

26.1

31.1

32.1

European population

(37.8-42.0)

(63.7-67.9)

(20.7-24.7)

(24.8-29.2)

(42.8-47.0)

(23.1-27.0)

(24.1-28.2)

(28.9-33.2)

(29.9-34.2)

Sex

         

Men

33.8

63.7

29.0

23.7

57.7

32.0

28.2

36.9

38.9

 

(30.6-37.0)

(60.5-66.9)

(25.7-32.2)

(20.6-26.8)

(54.4-61.0)

(29.0-35.1)

(25.1-31.2)

(33.6-40.2)

(35.6-42.2)

Women

46.6

68.3

17.4

30.3

37.1

20.9

26.3

28.1

28.4

 

(44.0-49.2)

(65.7-70.9)

(15.1-19.8)

(27.3-33.4)

(34.8-39.5)

(18.5-23.3)

(23.8-28.9)

(25.5-30.8)

(25.8-31.0)

Age, years

         

20-29

10.7

27.8

8.2

16.8

16.5

3.8

3.4

6.2

6.2

 

(7.1-14.2)

(22.8-32.9)

(5.1-11.3)

(12.6-21.0)

(12.3-20.6)

(1.6-5.9)

(1.3-5.5)

(3.4-9.0)

(3.4-9.0)

30-39

22.3

53.7

20.7

25.4

23.1

8.7

12.5

18.1

19.2

 

(17.9-26.7)

(48.4-58.9)

(16.8-24.6)

(20.8-30.0)

(19.0-27.2)

(5.8-11.7)

(9.1-15.9)

(14.2-22.1)

(15.2-23.3)

40-49

33.8

69.6

22.2

26.3

38.3

22.9

21.1

29.5

30.2

 

(28.1-39.5)

(63.9-75.2)

(17.4-27.0)

(21.1-31.5)

(33.0-43.5)

(18.2-27.7)

(16.3-26.0)

(24.3-34.8)

(24.9-35.5)

50-59

59.2

85.0

31.3

30.4

58.0

35.5

37.4

39.6

42.1

 

(53.4-64.9)

(80.4-89.6)

(25.0-37.6)

(24.1-36.7)

(51.5-64.6)

(29.2-41.9)

(30.8-43.9)

(33.0-46.3)

(35.4-48.7)

60-69

71.4

92.2

32.4

37.7

80.2

49.8

53.6

57.8

58.9

 

(65.4-77.3)

(88.7-95.7)

(26.1-38.6)

(31.4-44.0)

(74.9-85.5)

(42.9-56.6)

(46.9-60.3)

(51.0-64.5)

(52.3-65.6)

70+

69.3

88.6

28.3

32.2

88.7

53.2

52.6

59.6

60.3

 

(64.2-74.4)

(84.6-92.6)

(22.7-34.0)

(26.4-38.0)

(84.6-92.8)

(47.0-59.5)

(46.4-58.7)

(53.5-65.8)

(54.2-66.5)

Residence

         

Urban

39.7

64.9

21.7

26.9

45.0

25.3

26.1

30.7

31.7

 

(37.4-42.1)

(62.5-67.3)

(19.5-23.9)

(24.4-29.4)

(42.8-47.3)

(23.1-27.5)

(23.9-28.4)

(28.4-33.1)

(29.4-34.1)

Rural

43.5

69.9

26.1

28.4

51.6

28.4

30.5

36.8

37.9

 

(39.5-47.6)

(66.0-73.8)

(21.9-30.2)

(24.1-32.7)

(47.5-55.7)

(24.3-32.5)

(26.5-34.6)

(32.4-41.1)

(33.5-42.3)

Education

         

Little or no formal education

72.8

90.7

33.0

37.3

79.1

45.4

51.7

56.4

57.3

 

(68.7-76.8)

(88.0-93.5)

(28.4-37.5)

(32.7-41.9)

(75.2-83.0)

(40.6-50.3)

(46.8-56.5)

(51.6-61.3)

(52.4-62.1)

Primary

49.8

79.3

23.7

26.5

55.8

33.8

34.1

38.2

39.4

 

(44.1-55.5)

(74.6-84.0)

(18.8-28.6)

(21.4-31.5)

(50.2-61.4)

(28.5-39.1)

(28.7-39.6)

(32.7-43.8)

(33.8-44.9)

Secondary

25.2

53.4

18.4

25.1

29.4

13.7

14.4

20.0

21.2

 

(21.7-28.7)

(49.4-57.4)

(15.3-21.4)

(21.6-28.7)

(25.8-33.0)

(11.0-16.4)

(11.6-17.2)

(16.8-23.2)

(17.9-24.4)

University

19.6

45.7

16.7

18.4

28.5

16.7

12.7

18.6

18.8

 

(15.1-24.1)

(40.2-51.2)

(12.6-20.9)

(14.0-22.9)

(23.5-33.5)

(12.6-20.8)

(8.9-16.4)

(14.2-22.9)

(14.5-23.2)

Glucose status

         

Normoglycaemia

31.8

58.2

16.9

24.0

35.6

0.0

11.8

15.9

16.1

 

(29.4-34.2)

(55.6-60.8)

(14.8-19.0)

(21.5-26.4)

(33.1-38.1)

 

(10.0-13.6)

(13.9-18.0)

(14.1-18.2)

Impaired fasting glucose

61.3

87.7

34.5

31.5

73.3

100

66.2

76.5

78.9

 

(55.2-67.3)

(83.5-91.9)

(28.5-40.4)

(25.6-37.5)

(67.7-78.9)

 

(60.3-72.2)

(71.1-81.9)

(73.8-84.0)

Diabetes

72.3

90.4

45.9

43.5

84.0

98.2

76.9

81.9

85.2

 

(65.5-79.1)

(85.9-94.8)

38.4-53.3)

(36.2-50.9)

(78.5-89.5)

(96.3-100)

(70.7-83.2)

(76.1-87.8)

(79.9-90.5)

  1. R-ATPIII: Revised National Cholesterol Education Program Adult Treatment Panel III. IDF: International Diabetes Federation.
  2. JIS 94/80: Joint Interim Statement with waist-circumference cut-off points of ≥94 cm for men and ≥80 cm for women
  3. 1Waist circumference ≥102 cm for men and ≥88 cm for women
  4. 2Waist circumference ≥94 cm for men and ≥80 cm for women